Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells

References

1. Aguzzi A., Montrasio F., Kaeser P. S. 2001; Prions: health scare and biological challenge. Nat Rev Mol Cell Biol 2:118–126
   [Google Scholar]
2. Almeida P. C., Nantes I. L., Chagas J. R., Rizzi C. C., Faljoni-Alario A., Carmona E., Juliano L., Nader H. B., Tersariol I. L. 2001; Cathepsin B activity regulation. Heparin-like glycosaminoglycans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem 276:944–951
   [Google Scholar]
3. Barrett A. J., Kirschke H. 1981; Cathepsin B, cathepsin H and cathepsin L. In Methods in Enzymology pp  535–561 Edited by Colowick S. P., Kaplan N. O. New York: Academic Press;
   [Google Scholar]
4. Bosque P. J., Prusiner S. B. 2000; Cultured cell sublines highly susceptible to prion infection. J Virol 74:4377–4386
   [Google Scholar]
5. Caughey B. 1994; Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues. Philos Trans R Soc Lond Ser B 343:399–404
   [Google Scholar]
6. Caughey B., Chesebro B. 2001; Transmissible spongiform encephalopathies and prion protein interconversions. Adv Virus Res 56:277–311
   [Google Scholar]
7. Caughey B., Raymond G. J. 1993; Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67:643–650
   [Google Scholar]
8. Caughey B., Raymond G. J., Ernst D., Race R. E. 1991; N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65:6597–6603
   [Google Scholar]
9. Collinge J. 2001; Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519–550
   [Google Scholar]
10. Dandoy-Dron F., Guillo F., Benboudjema L., Deslys J. P., Lasmezas C., Dormont D., Tovey M. G., Dron M. 1998; Gene expression in scrapie: cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J Biol Chem 273:7691–7697
    [Google Scholar]
11. Diedrich J. F., Minnigan H., Carp R. I., Whitaker J. N., Race R., Frey W., Haase A. T. 1991; Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65:4759–4768
    [Google Scholar]
12. Doh-ura K., Iwaki T., Caughey B. 2000; Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 74:4894–4897
    [Google Scholar]
13. Dolbeare F. A., Smith R. E. 1977; Flow cytometric measurement of peptidases with use of 5-nitrosalicylaldehyde and 4-methoxy-beta-naphthylamine derivatives. Clin Chem 23:1485–1491
    [Google Scholar]
14. Fairbairn D. W., Carnahan K. G., Thwaits R. N., Grigsby R. V., Holyoak G. R., O'Neill K. L. 1994; Detection of apoptosis induced DNA cleavage in scrapie-infected sheep brain. FEMS Microbiol Lett 115:341–346
    [Google Scholar]
15. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. 1993; Neurotoxicity of a prion protein fragment. Nature 362:543–546
    [Google Scholar]
16. Giese A., Groschup M. H., Hess B., Kretzschmar H. A. 1995; Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 5:213–221
    [Google Scholar]
17. Gray F., Chretien F., Adle-Biassette H., Dorandeu A., Ereau T., Delisle M. B., Kopp N., Ironside J. W., Vital C. 1999; Neuronal apoptosis in Creutzfeldt–Jakob disease. J Neuropathol Exp Neurol 58:321–328
    [Google Scholar]
18. Guicciardi M. E., Deussing J., Miyoshi H., Bronk S. F., Svingen P. A., Peters C., Kaufmann S. H., Gores G. J. 2000; Cathepsin B contributes to TNF- α -mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c . J Clin Invest 106:1127–1137
    [Google Scholar]
19. Ishidoh K., Kominami E. 1995; Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun 217:624–631
    [Google Scholar]
20. Ishisaka R., Utsumi T., Kanno T., Arita K., Katunuma N., Akiyama J., Utsumi K. 1999; Participation of a cathepsin L-type protease in the activation of caspase-3. Cell Struct Funct 24:465–470
    [Google Scholar]
21. Kegel K. B., Kim M., Sapp E., McIntyre C., Castano J. G., Aronin N., DiFiglia M. 2000; Huntingtin expression stimulates endosomal–lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20:7268–7278
    [Google Scholar]
22. Kingham P. J., Pocock J. M. 2001; Microglial secreted cathepsin B induces neuronal apoptosis. J Neurochem 76:1475–1484
    [Google Scholar]
23. Kopacek J., Sakaguchi S., Shigematsu K., Nishida N., Atarashi R., Nakaoke R., Moriuchi R., Niwa M., Katamine S. 2000; Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J Virol 74:411–417
    [Google Scholar]
24. Lotem J., Sachs L. 1996; Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc Natl Acad Sci U S A 93:12507–12512
    [Google Scholar]
25. McKinley M. P., Taraboulos A., Kenaga L., Serban D., Stieber A., DeArmond S. J., Prusiner S. B., Gonatas N. 1991; Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest 65:622–630
    [Google Scholar]
26. Prusiner S. B. 2001; Shattuck lecture – neurodegenerative diseases and prions. N Engl J Med 344:1548–1551
    [Google Scholar]
27. Rozman J., Stojan J., Kuhelj R., Turk V., Turk B. 1999; Autocatalytic processing of recombinant human procathepsin B is a bimolecular process. FEBS Lett 459:358–362
    [Google Scholar]
28. Saborio G. P., Permanne B., Soto C. 2001; Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810–813
    [Google Scholar]
29. Snow A. D., Wight T. N., Nochlin D., Koike Y., Kimata K., DeArmond S. J., Prusiner S. B. 1990; Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann–Sträussler syndrome, Creutzfeldt–Jakob disease and scrapie. Lab Invest 63:601–611
    [Google Scholar]
30. Ulbricht B., Spiess E., Schwartz-Albiez R., Ebert W. 1995; Quantification of intracellular cathepsin activities in human lung tumor cell lines by flow cytometry. Biol Chem Hoppe Seyler 376:407–414
    [Google Scholar]
31. Vancompernolle K., Van Herreweghe F., Pynaert G. 7 other authors 1998; Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 438:150–158
    [Google Scholar]
32. Wong C., Xiong L. W., Horiuchi M., Raymond L., Wehrly K., Chesebro B., Caughey B. 2001; Sulfated glycans and elevated temperature stimulate PrP^Sc-dependent cell-free formation of protease-resistant prion protein. EMBO J 20:377–386
    [Google Scholar]
33. Yamashima T. 2000; Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62:273–295
    [Google Scholar]
34. Zhang Y., Poirier G. G., Bürkle A. 2002; In situ analysis of cellular poly(ADP-ribose) production in scrapie-infected mouse neuroblastoma cells. Histochem J 34:357–363
    [Google Scholar]